TipRanks
NurExone Biologic (DE:J90)
FRANKFURT:J90
Germany Market

NurExone Biologic (J90) Cash flow

4 Followers

NurExone Biologic Cash Flow

DE:J90's free cash flow for Q2 2026 was $-990.00K. For the 2026 fiscal year, DE:J90's free cash flow was decreased by $971.00K and operating cash flow was $-956.00K. See a summary of the company’s cash flow.
Cash Flow
Mar 26Mar 25Mar 24Dec 22Mar 22
Operating Cash Flow
$ -4.51M$ -4.89M$ -2.94M$ -3.85M$ -1.21M
Investing Cash Flow
$ -55.00K$ -658.00K$ -97.00K$ -89.00K$ 0.00
Financing Cash Flow
$ 5.83M$ 5.88M$ 1.13M$ 4.29M$ 3.40M
End Cash Position
$ 2.14M$ 700.00K$ 541.00K$ 2.46M$ 2.21M
Free Cash Flow
$ -4.57M$ -5.54M$ -3.06M$ -3.90M$ -1.21M
Currency in USD

NurExone Biologic Cash Flow